CN103097887A - 用于分离水溶性生物物质的方法 - Google Patents
用于分离水溶性生物物质的方法 Download PDFInfo
- Publication number
- CN103097887A CN103097887A CN2011800434683A CN201180043468A CN103097887A CN 103097887 A CN103097887 A CN 103097887A CN 2011800434683 A CN2011800434683 A CN 2011800434683A CN 201180043468 A CN201180043468 A CN 201180043468A CN 103097887 A CN103097887 A CN 103097887A
- Authority
- CN
- China
- Prior art keywords
- separating agent
- water
- acid
- separating
- chromatogram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012620 biological material Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 101
- 239000000126 substance Substances 0.000 claims abstract description 38
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 33
- 239000005017 polysaccharide Substances 0.000 claims abstract description 33
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 19
- 229920002678 cellulose Polymers 0.000 claims abstract description 15
- 239000001913 cellulose Substances 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 108020004707 nucleic acids Proteins 0.000 claims description 28
- 102000039446 nucleic acids Human genes 0.000 claims description 28
- 229940088594 vitamin Drugs 0.000 claims description 23
- 229930003231 vitamin Natural products 0.000 claims description 23
- 235000013343 vitamin Nutrition 0.000 claims description 23
- 239000011782 vitamin Substances 0.000 claims description 23
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 23
- 150000001413 amino acids Chemical class 0.000 claims description 22
- 241001597008 Nomeidae Species 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 21
- 235000000346 sugar Nutrition 0.000 claims description 20
- 229920000856 Amylose Polymers 0.000 claims description 15
- -1 nucleic acid compound Chemical class 0.000 claims description 15
- 108010038807 Oligopeptides Proteins 0.000 claims description 7
- 102000015636 Oligopeptides Human genes 0.000 claims description 7
- 241001072909 Salvia Species 0.000 claims description 6
- 235000017276 Salvia Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 abstract description 8
- 239000004382 Amylase Substances 0.000 abstract 1
- 102000013142 Amylases Human genes 0.000 abstract 1
- 108010065511 Amylases Proteins 0.000 abstract 1
- 235000019418 amylase Nutrition 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 48
- 238000004128 high performance liquid chromatography Methods 0.000 description 38
- 238000000926 separation method Methods 0.000 description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- 150000004804 polysaccharides Chemical class 0.000 description 28
- 239000012488 sample solution Substances 0.000 description 28
- 229940024606 amino acid Drugs 0.000 description 22
- 239000002777 nucleoside Substances 0.000 description 22
- 125000003835 nucleoside group Chemical group 0.000 description 22
- 235000001014 amino acid Nutrition 0.000 description 20
- 150000007523 nucleic acids Chemical class 0.000 description 20
- 238000002347 injection Methods 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 108010016626 Dipeptides Proteins 0.000 description 12
- 235000010980 cellulose Nutrition 0.000 description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 11
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 11
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 9
- 229920001503 Glucan Polymers 0.000 description 9
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000019257 ammonium acetate Nutrition 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 235000001968 nicotinic acid Nutrition 0.000 description 9
- 229960003512 nicotinic acid Drugs 0.000 description 9
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 9
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 239000005695 Ammonium acetate Substances 0.000 description 7
- 229940043376 ammonium acetate Drugs 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000011664 nicotinic acid Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 230000018044 dehydration Effects 0.000 description 6
- 238000006297 dehydration reaction Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 235000017103 tryptophane Nutrition 0.000 description 6
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- 239000006035 Tryptophane Substances 0.000 description 5
- 229960001238 methylnicotinate Drugs 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 229960004799 tryptophan Drugs 0.000 description 5
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 4
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 4
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 229960003767 alanine Drugs 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 229940029575 guanosine Drugs 0.000 description 4
- 235000005772 leucine Nutrition 0.000 description 4
- 238000004811 liquid chromatography Methods 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 235000013930 proline Nutrition 0.000 description 4
- 229960002429 proline Drugs 0.000 description 4
- 235000004400 serine Nutrition 0.000 description 4
- 229940104230 thymidine Drugs 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 4
- 229940045145 uridine Drugs 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- BLHCMGRVFXRYRN-UHFFFAOYSA-N 6-hydroxynicotinic acid Chemical compound OC(=O)C1=CC=C(O)N=C1 BLHCMGRVFXRYRN-UHFFFAOYSA-N 0.000 description 3
- RDIKFPRVLJLMER-BQBZGAKWSA-N Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)N RDIKFPRVLJLMER-BQBZGAKWSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 3
- RXJFSLQVMGYQEL-IHRRRGAJSA-N Glu-Tyr-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 RXJFSLQVMGYQEL-IHRRRGAJSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229920000057 Mannan Polymers 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 239000006087 Silane Coupling Agent Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
- 229960005261 aspartic acid Drugs 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 229940118199 levulan Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229960001153 serine Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- 229920001221 xylan Polymers 0.000 description 3
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 229920000519 Sizofiran Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003254 radicals Chemical group 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229950001403 sizofiran Drugs 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 238000004808 supercritical fluid chromatography Methods 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- BEOUGZFCUMNGOU-UHFFFAOYSA-N tuberculostearic acid Chemical compound CCCCCCCCC(C)CCCCCCCCC(O)=O BEOUGZFCUMNGOU-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- SBTVLCPCSXMWIQ-UHFFFAOYSA-N (3,5-dimethylphenyl) carbamate Chemical class CC1=CC(C)=CC(OC(N)=O)=C1 SBTVLCPCSXMWIQ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- HKKCQZRJLCIYQD-NPDZVAPOSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-3,4-dihydro-1H-isochromen-1-yl]thiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound S(N)(OC[C@@H]1[C@H](C[C@@H](C1)NC1=NC=NC=C1C(=O)C=1SC=C(C=1)[C@@H]1OCCC2=CC=CC=C12)O)(=O)=O HKKCQZRJLCIYQD-NPDZVAPOSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000003838 adenosines Chemical class 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 150000001510 aspartic acids Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 229940010007 cobalamins Drugs 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- AUMSSPWMPHCFQA-UHFFFAOYSA-N hydroxy(sulfanyl)silane Chemical group O[SiH2]S AUMSSPWMPHCFQA-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000004425 isosulfocyanate group Chemical group 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- ICXWPWNCVZCKEG-UHFFFAOYSA-M lithium;2-methylpropanamide;chloride Chemical compound [Li+].[Cl-].CC(C)C(N)=O ICXWPWNCVZCKEG-UHFFFAOYSA-M 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- SWDYEOBSKYXKLZ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O SWDYEOBSKYXKLZ-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- DWRXFEITVBNRMK-JXOAFFINSA-N ribothymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 DWRXFEITVBNRMK-JXOAFFINSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 150000003654 tryptophanes Chemical class 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/288—Polar phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3221—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond the chemical bond being an ionic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K1/00—Glucose; Glucose-containing syrups
- C13K1/02—Glucose; Glucose-containing syrups obtained by saccharification of cellulosic materials
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K11/00—Fructose
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K13/00—Sugars not otherwise provided for in this class
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K13/00—Sugars not otherwise provided for in this class
- C13K13/002—Xylose
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
提供的是用于分离水溶性生物物质的新方法。分离剂通过经由化学键合使多糖例如纤维素或直链淀粉与载体表面结合而构成,并且使用分离剂通过层析从两个或更多个类型的水溶性生物物质的混合物中分离水溶性生物物质。
Description
技术领域
本发明涉及用于分离水溶性生物物质的方法。
背景技术
因为具有生理活性的生物物质例如以糖、核酸化合物、氨基酸、蛋白质、维生素或酸性化合物形式的物质证实体内的有效作用,几乎所有这些物质都是水溶性的,并且作为其结果,在反相条件下的层析方法频繁应用于分析几乎所有这些物质。
另一方面,近来已存在描述使用含有几个百分比到40%的水的流动相,通过含水正相层析来层析分离且分析这些生物水溶性生理活性物质的尝试的众多报道(参见例如,非专利文件1)。这个含水正相层析称为亲水作用液相层析(HILIC),并且视为提供可容易应用于LC-MS的分析模式,因为它使弱保留且难以通过反相层析分离的化合物分离成为可能,并且仅使用挥发性有机溶剂和水用于流动相,而不使用高度浓缩的盐或离子对试剂。
尽管大多数这些HILIC分离柱在大多数情况下使用二氧化硅、胺修饰的或酰胺修饰的分离剂,并且其他柱的例子包括聚胺、聚丙烯酸、聚乙烯、环糊精和两性离子柱,但存在在具有多种官能团、结构和物理性质的广泛范围的生物化合物的分离和分析过程中能够更有效分离的HILIC分离剂的需要(参见例如,非专利文件2)。
例如,层析技术例如高效液相层析(HPLC)已知作为用于分离单糖、多糖和糖醇等的方法。用于分离此类糖的分离剂的例子包括通过使聚丙烯酰胺与二氧化硅凝胶化学键合获得的分离剂和通过将聚烷撑聚胺与二氧化硅凝胶化学键合获得的分离剂(参见例如,专利文件1和2)。此外,用于分离糖的方法的已知例子包括将由水溶胀的纤维素填充到柱管内,并且使用水和醇的混合物作为洗脱剂通过柱层析分离寡糖(参见例如,专利文件3)。另一方面,使用多糖衍生物例如纤维素的分离剂的已知例子是通过将纤维素或直链淀粉例如二甲基苯基氨基甲酸酯衍生物的多糖衍生物与二氧化硅凝胶化学键合获得的用于光学异构体分离的分离剂(参见例如,专利文件4)。
[专利文件1]日本专利公开号2504005
[专利文件2]日本专利公开号2558007
[专利文件3]日本专利公开号3885912
[专利文件4]日本专利公开号2751004
[非专利文件1] Journal of Chromatography A,1994,第676卷,第191-202页
[非专利文件2] Journal of Separation Science,2006,第29卷,第1784-1821页。
发明内容
本发明提供了用于分离水溶性生物物质的新方法。
本发明的发明人发现通过将多糖与二氧化硅凝胶化学键合获得的分离剂对于将水溶性生物物质分离成个别化合物是优异的,从而导致本发明的完成。
即,本发明提供了使用由载体和通过化学键合与载体表面结合的多糖组成的分离剂通过层析,用于从两个或更多个类型的水溶性生物物质的混合物中分离水溶性生物物质的方法。
此外,本发明提供了用于分离水溶性生物物质的分离剂,其由载体和通过化学键合与载体表面结合的多糖组成。
此外,本发明提供了上述方法和分离剂,其中水溶性生物物质是其选自糖、核酸化合物、氨基酸、水溶性维生素、具有生理活性的酸性化合物及其衍生物、和寡肽的一个或多个类型。
此外,本发明提供了上述方法和分离剂,其中多糖是纤维素或直链淀粉。
因为本发明使用以由载体和通过化学键合与载体表面结合的多糖组成的分离剂形式的、先前未知具有将水溶性生物物质分离成个别化合物的能力的分离剂,所以它能够提供用于分离水溶性生物物质的新方法。
附图说明
图1是显示使用实施例的分离剂1通过HPLC由RI检测器获得的糖分离的层析谱的图;
图2是显示使用实施例的分离剂1通过HPLC由UV检测器获得的糖分离的层析谱的图;
图3是显示使用实施例的分离剂2通过HPLC由RI检测器获得的糖分离的层析谱的图;
图4是显示使用实施例的分离剂2通过HPLC由UV检测器获得的糖分离的层析谱的图;
图5是显示使用实施例的分离剂1通过HPLC由UV检测器获得的核酸碱基分离的层析谱的图;
图6是显示使用实施例的分离剂2通过HPLC由UV检测器获得的核酸碱基分离的层析谱的图;
图7是显示使用实施例的分离剂1通过HPLC由UV检测器获得的核苷分离的层析谱的图;
图8是显示使用实施例的分离剂2通过HPLC由UV检测器获得的核苷分离的层析谱的图;
图9是显示使用实施例的分离剂1通过HPLC由UV检测器获得的水溶性维生素分离的层析谱的图;
图10是显示使用实施例的分离剂2通过HPLC由UV检测器获得的水溶性维生素分离的层析谱的图;
图11是显示使用实施例的分离剂1通过HPLC由UV检测器获得的氨基酸分离的层析谱的图;
图12是显示使用实施例的分离剂2通过HPLC由UV检测器获得的氨基酸分离的层析谱的图;
图13是显示使用实施例的分离剂1通过HPLC由UV检测器获得的具有生理活性的酸性化合物及其衍生物分离的层析谱的图;
图14是显示使用实施例的分离剂2通过HPLC由UV检测器获得的具有生理活性的酸性化合物及其衍生物分离的层析谱的图;
图15是显示使用实施例的分离剂2通过HPLC由UV检测器获得的核酸碱基和核苷混合物分离的层析谱的图;
图16是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的核酸碱基分离的层析谱的图;
图17是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的核苷分离的层析谱的图;
图18是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的水溶性维生素分离的层析谱的图;
图19是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的氨基酸分离的层析谱的图;
图20是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的具有生理活性的酸性化合物及其衍生物分离的层析谱的图;
图21是显示使用实施例的分离剂1通过HPLC由UV检测器获得的二肽和三肽混合物分离的层析谱的图;
图22是显示使用实施例的分离剂2通过HPLC由UV检测器获得的二肽和三肽混合物分离的层析谱的图;和
图23是显示使用商购可得的ODS柱通过HPLC由UV检测器获得的二肽和三肽混合物分离的层析谱的图。
具体实施方式
在本发明中,使用由载体和通过化学键合与载体表面结合的多糖组成的用于水溶性生物物质的分离剂。在本发明用于分离水溶性生物物质的方法中,个别水溶性生物物质使用上文提及的本发明的分离剂通过层析从两个或更多个类型的水溶性生物物质的混合物中分离。
通常用作用于层析的分离剂的载体的载体可以用于上文提及的载体。上文提及的载体优选多孔载体。此类多孔载体的例子包括多孔无机载体和多孔有机载体。多孔无机载体的例子包括二氧化硅凝胶、硅藻土、多孔玻璃、羟磷灰石、氧化铝、氧化钛和氧化镁。多孔有机载体的例子包括聚丙烯酰胺和聚丙烯酸酯。
上文提及的载体可以以通常用于柱层析的形式使用。此类形式的例子包括填充到柱管内的颗粒、在柱管中含有的多孔圆柱体、和在薄膜分离中使用的多孔薄膜。从通用性和分离剂的容易制备的观点来看,上文提及的载体优选是二氧化硅凝胶。从所得到的峰理论塔板数和压力损失之间的平衡的观点来看,二氧化硅凝胶的粒径优选1 μm - 1,000 μm,且更优选2 μm - 100 μm。从比表面积和高分子量化合物渗透到孔内之间的平衡的观点来看,二氧化硅凝胶的平均孔径优选1 nm - 100 μm,且更优选2 nm - 500 nm。
具有还原末端的多糖可以用于上文提及的多糖。此类多糖可以选自合成多糖和天然存在的多糖。从识别分析靶的形状的观点来看,具有高度规则键合结构的多糖优选用于上文提及的多糖。此类多糖的例子包括α-1,4-葡聚糖(直链淀粉)、β-1,4-葡聚糖(纤维素)、α-1,6-葡聚糖(葡聚糖)、β-1,6-葡聚糖(石耳素)、α-1,3-葡聚糖、β-1,3-葡聚糖(例如凝乳聚糖(curdlan)或西佐糖(sizofiran))、α-1,2-葡聚糖、β-1,2-葡聚糖、β-1,4-壳聚糖、β-1,4-N-乙酰壳聚糖(壳多糖)、β-1,4-半乳聚糖、α-1,6-半乳聚糖、β-1,2-果聚糖(菊粉)、β-2,6-果聚糖(果聚糖)、β-1,4-木聚糖、β-1,3-木聚糖、β-1,4-甘露聚糖、α-1,6-甘露聚糖、支链淀粉、琼脂糖、海藻酸和具有高直链淀粉含量的淀粉。
从使高度纯化的多糖能够容易获得的观点来看,上文提及的多糖优选纤维素、直链淀粉、β-1,4-壳聚糖、壳多糖、β-1,4-甘露聚糖、β-1,4-木聚糖、菊粉或凝乳聚糖,且更优选纤维素或直链淀粉。
从通过单体的重复聚合作用构建规则高阶结构的观点来看,上文提及的多糖的数目平均聚合度优选11或更多。尽管不存在关于多糖的数目平均聚合度的特定上限,但从处理容易的观点来看,500或更少的值是优选的。
在本发明中,多糖通过化学键合与载体结合。多糖可以通过化学键合例如共价键合或离子键合与载体表面直接结合,或可以经由固定在载体表面上的间隔物分子结合。此类间隔物分子可以根据载体的类型适当地选择。
例如,具有与二氧化硅凝胶表面上的硅烷醇基键合的第一个官能团和与多糖的还原末端化学键合的第二个官能团的化合物可以用作用于二氧化硅凝胶的上文提及的间隔物分子。第一个官能团的例子包括硅烷基和硅烷氧基(silanoxy)。第二个官能团的例子包括乙烯基、氨基、羟基、羧基、醛基、异氰酸根基团、硫氰酸根基团、异硫氰酸根基团、硫醇基、硅烷醇基、环氧基、醚基、酯基、酰胺基和卤素原子。
上文提及的间隔物分子优选含有用于第一个官能团的氨基的化合物,且优选伯胺化合物。可以使用的此类间隔物分子的例子包括商购可得的硅烷偶联剂和其中氨基已引入这些硅烷偶联剂内的化合物。
上文提及的分离剂可以通过例如用间隔物分子表面处理载体或化学键合表面处理的载体和多糖获得。
在载体是二氧化硅凝胶的情况下,例如用间隔物分子的载体表面处理可以通过使用已知方法使具有氨基的硅烷偶联剂例如3-氨基丙基三乙氧基硅烷与二氧化硅凝胶的表面化学键合执行。
在表面处理的载体和多糖之间的化学键合可以通过还原胺化执行,通过例如将具有还原末端的多糖溶解于溶剂例如二甲基亚砜(DMSO)或氯化锂-二甲基乙酰胺(DMA/LiCl)中,加入还原剂,并且在50℃ - 80℃反应12小时,以使上文提及的表面处理的二氧化硅凝胶表面上存在的氨基与多糖的还原末端化学键合。
合适的化合物可以选自用于上文提及的还原剂的已知还原剂中,并且其例子包括NaBH4(硼氢化钠)、NaBH3CN(氰基硼氢化钠)和硼烷化合物例如硼烷-吡啶络合物、硼烷-二甲胺络合物或硼烷三甲胺。还原胺化可以通过进一步将乙酸加入反应系统中在中性条件下在pH 6 - pH 8附近执行。
尽管对其不存在具体限制,但通常用于形成分离剂的多糖的量优选基于使用的载体的量按重量计约5% - 按重量计50%。此外,从抑制残留硅烷醇基的作用的观点来看,优选对分离剂实施封端处理。封端可以根据已知方法执行,并且由于这种处理,分离剂的分离能力可以进一步得到稳定或改善。
如本发明中提及的“水溶性”物质指当水用作溶剂时,溶解于水中的那种,并且在本发明中分离的上文提及的水溶性生物物质包括具有相当低的分子量或多个氢键的极性分子晶体,以及在水溶液中贡献或接受质子的那些。此外,如本发明中提及的“水溶性的”指在水中具有0.001%(10 ppm)或更多的溶解度。水溶性生物物质的分子量包括大致30 - 10,000的分子量。如本发明中提及的“水溶性生物物质”包括组成机体(body)的水溶性物质,在由机体代谢中使用的水溶性物质,和具有生理活性的水溶性物质。
此类水溶性生物物质的具体例子包括核酸化合物包括核酸碱基和核苷、水溶性维生素、氨基酸、具有生理活性的酸性化合物及其衍生物、和寡肽。
属于下文列出相同范畴的仅充当分析靶的那些水溶性生物物质可以靶向用于分析,或其中含有属于不同范畴的那些物质的混合物可以靶向用于分析。
在本发明中分离的上文提及的核酸化合物的例子包括核酸碱基,包括胸腺嘧啶、尿嘧啶、腺嘌呤、胞嘧啶和鸟嘌呤,和以核糖核苷形式的核苷,包括5-甲基尿苷、尿苷、腺苷、胞苷和鸟苷,和以脱氧核糖核苷形式的核苷,包括胸苷、脱氧尿苷、脱氧腺苷、脱氧胞苷和脱氧鸟苷。
在本发明中分离的上文提及的水溶性维生素的例子包括维生素C、维生素B1、维生素B2、维生素B3包括烟酸和烟酰胺、维生素B5、维生素B6、维生素B7、维生素B9和维生素B12。
在本发明中分离的上文提及的氨基酸优选α-氨基酸,并且组成蛋白质的其例子包括丙氨酸、精氨酸、天冬酰胺、天冬氨酸、半胱氨酸、谷氨酰胺、谷氨酸、甘氨酸、组氨酸、异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、色氨酸、酪氨酸和缬氨酸。
在本发明中分离的上文提及的具有生理活性的酸性化合物及其衍生物优选具有1 – 500个碳原子且更优选具有1 – 300个碳原子和羧基。如本发明中提及的“生理活性”指由作用于机体的特定生理调节功能的物质具有的那种。
上文提及的酸性化合物及其衍生物的例子包括吡啶甲酸及其中含氮六元环的任意氢原子由羟基取代的其衍生物,其中羧基由具有1 – 3个碳原子的醇酯化的衍生物,和其中含氮六元环的任意氢原子由羟基取代和羧基被酯化的衍生物。具体例子包括烟酸、烟酸甲酯、6-羟基烟酸和5-羟基烟酸。
此外,在以甲酸、乙酸、丙酸、丁酸、异丁酸、戊酸、异戊酸、己酸、庚酸、辛酸、壬酸、癸酸、月桂酸、肉豆蔻酸、十五酸、棕榈酸、十七酸、硬脂酸、油酸、亚油酸、亚麻酸、结核硬脂酸(tuberculostearic acid)、花生酸、花生四烯酸、二十碳五烯酸、山嵛酸、二十二碳六烯酸、二十四烷酸、蜡酸、褐煤酸(montanoic acid)和蜂花酸(mellisic acid)的形式的脂肪酸和不饱和脂肪酸的情况下,其反式和顺式异构体也是分析靶的具体例子。
在本发明中分离的上文提及的寡肽的例子优选具有5个或更少氨基酸残基,并且更优选三肽或二肽。组成肽的氨基酸残基的例子包括上文提及的α-氨基酸。
在本发明中分离的上文提及的糖的例子包括单糖例如葡萄糖、木糖或果糖,二糖例如麦芽糖、乳糖或蔗糖,和糖醇例如甘油。
上文提及的分离剂可以用作层析中的分离剂,所述层析使用微粒、圆柱状或薄膜样分离剂。此类层析的例子包括气相层析、液相层析、薄层层析、模拟移动床层析和超临界流体层析。这些层析方法可以通过普通方法执行,除了使用上文提及的分离剂外。
在这些层析方法中,液体例如水或多个类型的溶剂,或已知流体例如超临界流体或亚临界流体可以用于流动相。例如,在超临界流体层析的情况下,由超临界二氧化碳组成的超临界流体、由亚临界二氧化碳组成的亚临界流体、或超临界二氧化碳和添加剂的混合流体可以用于流动相。上文提及的添加剂的例子包括具有1 – 8个碳原子的醇、乙腈、丙酮、四氢呋喃、氯仿、二氯甲烷、乙酸酯、叔丁基甲醚和水。可以使用一个类型或两个或更多个类型的添加剂。
使用类似于普通层析那种的程序,除了在适合于分离水溶性生物物质的条件下执行外,使用上文提及的分离剂的层析可以用于分析样品中的水溶性生物物质,或从混合物中分离特定糖。用于分离水溶性生物物质的已知条件可以像这样使用,或由此类已知条件进一步衍生的条件可以用于水溶性生物物质的分离条件。
实施例
将12 mL脱水苯和1 mL脱水吡啶加入10 g通过在180℃真空干燥2小时初步活化的二氧化硅凝胶(FUJI SILYSIA CHEMICAL LTD.,平均孔径:50 nm,粒径:5 μm)中,随后加入0.7 mL 3-氨基丙基三乙氧基硅烷,并且在90℃反应12小时。在用甲醇、丙酮和己烷洗涤这个表面处理的二氧化硅凝胶后,将二氧化硅凝胶在60℃真空干燥2小时,以获得其中氨基丙基与其表面结合的表面处理的二氧化硅凝胶。
将通过使1.0 g直链淀粉(平均聚合度:160)溶解于8 mL脱水DMSO中获得的溶液加入所得到的表面处理的二氧化硅凝胶中,并且将通过将30 mg乙酸加入经由使150 mg NaBH3CN溶解于5 mL脱水DMSO中获得的溶液中而获得的溶液加入所得到的浆中,随后在氮的存在下在50℃反应12小时,以使表面处理的二氧化硅凝胶的氨基与直链淀粉的还原末端化学键合,且获得直链淀粉键合的二氧化硅凝胶。
使用G4玻璃滤器将所得到的直链淀粉键合的二氧化硅凝胶过滤,并且将残渣用DMSO、四氢呋喃、甲醇、丙酮和己烷洗涤,以从直链淀粉键合的二氧化硅凝胶中去除未结合的直链淀粉等,随后在60℃真空干燥2小时,以获得通过经由化学键合使直链淀粉与二氧化硅凝胶表面键合获得的分离剂1。分离剂1的元素分析值由C:4.29%,H:0.90%和N:0.22%组成。
此外,将通过使1.0 g纤维素(由MERCK制造,平均聚合度:200)溶解于21 mL脱水DMA/LiCl中获得的溶液加入上文提及的表面处理的二氧化硅凝胶中,并且将通过将30 mg乙酸加入经由使150 mg NaBH3CN溶解于5 mL脱水DMA/LiCl中获得的溶液中而获得的溶液加入所得到的浆中,随后在氮的存在下在50℃反应36小时,以使表面处理的二氧化硅凝胶的氨基与纤维素的还原末端化学键合,且获得纤维素键合的二氧化硅凝胶。
使用G4玻璃滤器将所得到的纤维素键合的二氧化硅凝胶过滤,并且将残渣用DMA/LiCl、四氢呋喃、甲醇、丙酮和己烷洗涤,以从纤维素键合的二氧化硅凝胶中去除未结合的纤维素等,随后在60℃真空干燥2小时,以获得通过经由化学键合使纤维素与二氧化硅凝胶表面键合获得的分离剂2。分离剂2的元素分析值由C:2.12%,H:0.56%和N:0.15%组成。
通过匀浆填充将分离剂1和2分别填充到具有0.46 cm内径和25 cm长度的不锈钢空柱,以分别获得含有填充的分离剂1的柱1和含有填充的分离剂2的柱2。此外,由KYOTO CHROMATO制造的PS10和PS-20自动填充系统用于将分离剂填充到柱内。
使用这些柱1和2通过HPLC评估分离剂1和2分离由葡萄糖、木糖、果糖、甘油、麦芽糖、乳糖和蔗糖组成的总共七个类型的糖的能力。通过将七个类型的糖以约4,000 ppm的浓度溶解于流动相中获得的溶液用于样品溶液。水和乙腈的混合物(水/乙腈= 25/75(体积比))用于流动相。流动相的流速是0.5 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是20 μL,并且RI检测器和UV检测器用于检测器。UV检测器的检测波长是190 nm。使用RI检测器用分离剂1的糖分离的层析谱显示于图1中,使用UV检测器用分离剂1的糖分离的层析谱显示于图2中,使用RI检测器用分离剂2的糖分离的层析谱显示于图3中,并且使用UV检测器用分离剂2的糖分离的层析谱显示于图4中。
<核酸碱基的分离>
使用上文提及的柱1和2通过HPLC评估分离剂1和2分离由胸腺嘧啶、尿嘧啶、腺嘌呤和胞嘧啶组成的总共四个类型的核酸碱基的能力。样品溶液含有各自以50 ppm浓度的四个类型的核酸碱基。10 mM乙酸铵水溶液和乙腈的混合物(10 mM AcONH4aq/CH3CN = 10/90(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是1 μL,并且UV检测器(254 nm)用于检测器。用分离剂1的核酸碱基分离的层析谱显示于图5中,并且用分离剂2的核酸碱基分离的层析谱显示于图6中。洗脱次序对于分离剂1和2是相同的。
(核酸碱基的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离由胸腺嘧啶、尿嘧啶、腺嘌呤和胞嘧啶组成的总共四个类型的核酸碱基的能力。样品溶液含有各自以250 ppm浓度的四个类型的核酸碱基。10 mM乙酸铵水溶液和乙腈的混合物(10 mM AcONH4aq/CH3CN = 90/10(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是1 μL,并且UV检测器(254 nm)用于检测器。用ODS柱的核酸碱基分离的层析谱显示于图16中。ODS柱不能保留核酸碱基化合物。
<核苷的分离>
使用上文提及的柱1和2通过HPLC评估分离剂1和2分离由胸苷、尿苷、腺苷、胞苷和鸟苷组成的核苷的能力。样品溶液含有各自以200 ppm浓度的五个类型的核苷。10 mM乙酸铵水溶液和乙腈的混合物(10 mM AcONH4aq/CH3CN = 10/90(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是1 μL,并且UV检测器(254 nm)用于检测器。用分离剂1的核苷分离的层析谱显示于图7中,并且用分离剂2的核苷分离的层析谱显示于图8中。洗脱次序对于分离剂1和2是相同的。
(核苷的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离由胸苷、尿苷、腺苷、胞苷和鸟苷组成的核苷的能力。样品溶液含有各自以200 ppm浓度的五个类型的核苷。10 mM乙酸铵水溶液和乙腈的混合物(10 mM AcONH4aq/CH3CN = 10/90(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是1 μL,并且UV检测器(254 nm)用于检测器。用ODS柱的核苷分离的层析谱显示于图17中。ODS柱不能保留核苷。
<水溶性维生素的分离的实施例>
使用上文提及的柱1和2通过HPLC评估分离剂1和2分离由烟酰胺、维生素B6、维生素B1、维生素B12和维生素C组成的水溶性维生素的能力。样品溶液含有各自以160 ppm浓度的五个类型的水溶性维生素。10 mM乙酸铵水溶液和乙腈的混合物(液体A:10 mM AcONH4aq,液体B:CH3CN,液体B:0分钟至10分钟(90% → 50%),10.01分钟至30分钟(50%))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是5 μL,并且UV检测器(254 nm)用于检测器。用分离剂1的水溶性维生素分离的层析谱显示于图9中,并且用分离剂2的水溶性维生素分离的层析谱显示于图10中。洗脱次序对于分离剂1和2是相同的。
(水溶性维生素的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离由烟酰胺、维生素B6、维生素B1、维生素B12和维生素C组成的水溶性维生素的能力。样品溶液含有各自以160 ppm浓度的五个类型的水溶性维生素。10 mM乙酸铵水溶液和乙腈的混合物(10 mM AcONH4aq/CH3CN = 90/10(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是3 μL,并且UV检测器(254 nm)用于检测器。用ODS柱的核苷分离的层析谱显示于图18中。ODS柱不能保留水溶性维生素。
<氨基酸的分离>
使用柱1和2通过HPLC评估分离剂1和2分离由色氨酸、亮氨酸、脯氨酸、丙氨酸、谷氨酸、天冬氨酸和丝氨酸组成的氨基酸的能力。样品溶液含有以8 ppm浓度的色氨酸和各自以800 ppm浓度的另外六个类型的氨基酸。20 mM磷酸盐缓冲液(pH = 6.2)和乙腈的混合物(20 mM H3PO4(pH = 6.2)缓冲液/CH3CN = 25/75(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是40℃,并且样品溶液的注射量是5 μL,并且UV检测器(200 nm)用于检测器。用分离剂1的氨基酸分离的层析谱显示于图11中,并且用分离剂2的氨基酸分离的层析谱显示于图12中。洗脱次序对于分离剂1和2是相同的。
(氨基酸的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离由色氨酸、亮氨酸、脯氨酸、丙氨酸、谷氨酸、天冬氨酸和丝氨酸组成的氨基酸的能力。样品溶液含有以8 ppm浓度的色氨酸和各自以800 ppm浓度的另外六个类型的氨基酸。20 mM磷酸盐缓冲液(pH = 6.2)和乙腈的混合物(20 mM H3PO4(pH = 6.2)缓冲液/CH3CN = 25/75(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是40℃,并且样品溶液的注射量是5 μL,并且UV检测器(200 nm)用于检测器。用ODS柱的氨基酸分离的层析谱显示于图19中。ODS柱不能保留氨基酸。
<具有生理活性的酸性化合物及其衍生物的分离>
使用柱1和2通过HPLC评估分离剂1和2分离烟酸甲酯、烟酸、6-羟基烟酸和5-羟基烟酸的能力。样品溶液含有以100 ppm浓度的烟酸甲酯和以250 ppm浓度的具有生理活性的另外酸性化合物及其衍生物。10 mM乙酸铵和乙腈的混合物(10 mM AcONH4/CH3CN = 10/90(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是40℃,并且样品溶液的注射量是5 μL,并且UV检测器(220 nm)用于检测器。用分离剂1的具有生理活性的酸性化合物及其衍生物的分离的层析谱显示于图13中,并且用分离剂2的具有生理活性的酸性化合物及其衍生物的分离的层析谱显示于图14中。洗脱次序对于分离剂1和2是相同的。
(具有生理活性的酸性化合物及其衍生物的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离烟酸甲酯、烟酸、6-羟基烟酸和5-羟基烟酸的能力。样品溶液含有以100 ppm浓度的烟酸甲酯和以250 ppm浓度的具有生理活性的另外酸性化合物及其衍生物。10 mM乙酸铵和乙腈的混合物(10 mM AcONH4/CH3CN = 10/90(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是5 μL,并且UV检测器(220 nm)用于检测器。用ODS柱的氨基酸分离的层析谱显示于图20中。ODS柱不能保留具有生理活性的酸性化合物及其衍生物。
<核酸碱基和核苷的混合物的分离>
使用柱2通过HPLC评估分离剂2分离总共九种化合物的能力,所述总共九种化合物包括由胸腺嘧啶、尿嘧啶、腺嘌呤和胞嘧啶组成的四个类型的核酸碱基和由胸苷、尿苷、腺苷、胞苷和鸟苷组成的五个类型的核苷。样品溶液含有各自以100 ppm浓度的四个类型的核酸碱基和各自以120 ppm浓度的五个类型的核苷。10 mM乙酸铵水溶液和乙腈的混合物(液体A:10 mM AcONH4aq,液体B:CH3CN,液体B:0分钟至20分钟(95% → 70%),20.01分钟至30分钟(70%))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是25℃,并且样品溶液的注射量是1 μL,并且UV检测器(254 nm)用于检测器。用分离剂2的核酸碱基和核苷混合物分离的层析谱显示于图15中。
<二肽和三肽的分离>
使用柱1和2通过HPLC评估分离剂1和2分离由H-Trp-Phe-OH、H-Ala-Leu-OH、H-Glu-Tyr-Glu-OH和H-Glu-Glu-OH组成的二肽和三肽的能力。样品溶液含有以70 ppm浓度的H-Trp-Phe-OH和各自以290 ppm浓度的另外三种样品。20 mM磷酸盐缓冲液(pH = 6.2)和乙腈的混合物(20 mM H3PO4(pH = 6.2)缓冲液/CH3CN = 40/60(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是40℃,并且样品溶液的注射量是3 μL,并且UV检测器(200 nm)用于检测器。用分离剂1的二肽和三肽分离的层析谱显示于图21中,并且用分离剂2的二肽和三肽分离的层析谱显示于图22中。洗脱次序对于分离剂1和2是相同的。
(二肽和三肽的分离:比较实施例)
使用商购可得的ODS柱(商品名称:L柱,Chemicals Evaluation and Research Institute,日本)通过HPLC评估用ODS柱分离由H-Trp-Phe-OH、H-Ala-Leu-OH、H-Glu-Tyr-Glu-OH和H-Glu-Glu-OH组成的二肽和三肽的能力。样品溶液含有以70 ppm浓度的H-Trp-Phe-OH和各自以290 ppm浓度的另外三种样品。20 mM磷酸盐缓冲液(pH = 6.2)和乙腈的混合物(20 mM H3PO4(pH = 6.2)缓冲液/CH3CN = 90/10(体积比))用于流动相。流动相的流速是1.0 mL/分钟,并且柱温是40℃,并且样品溶液的注射量是3 μL,并且UV检测器(200 nm)用于检测器。用ODS柱的二肽和三肽分离的层析谱显示于图23中。ODS柱不适合分离二肽和三肽。
如由图1-15以及图21和图22明确的是,分离剂1和2都致使能够充分分离糖、核酸化合物、氨基酸、水溶性维生素、酸性化合物及其衍生物和寡肽。此外,上文提及的分析靶的洗脱次序对于分离剂1和2是相同的。分离剂1证实比分离剂2更短的总洗脱时间,而分离剂2证实比分离剂1更大的在峰之间的距离。相应地,分离剂1预期应用于上文提及的分析靶的分析,而分离剂2预期应用于上文提及的分析靶的分离。
工业实用性
在此类领域如食品、化妆品、药物和农用化学品中,存在在体内证实有效作用的众多亲水或极性化合物,并且关于不由ODS柱保留的化合物的有效分离技术预期变得越来越复杂。相应地,本发明预期促进此类领域中的糖、核酸化合物、氨基酸、水溶性维生素、具有生理活性的酸性化合物及其衍生物和寡肽的改善生产率和更快速的分析,并且预期促成这些领域中的进一步进展。
符号的说明
1 甘油
2 木糖
3 果糖
4 葡萄糖
5 蔗糖
6 麦芽糖
7 乳糖
8 胸腺嘧啶
9 尿嘧啶
10 腺嘌呤
11 胞嘧啶
12 胸苷
13 尿苷
14 腺苷
15 胞苷
16 鸟苷
17 烟酰胺
18 维生素B6
19 维生素B1
20 维生素B12
21 维生素C
22 色氨酸
23 亮氨酸
24 脯氨酸
25 丙氨酸
26 谷氨酸
27 天冬氨酸
28 丝氨酸
29 烟酸甲酯
30 烟酸
31 6-羟基烟酸
32 5-羟基烟酸
33 H-Trp-Phe-OH
34 H-Ala-Leu-OH
35 H-Glu-Tyr-Glu-OH
36 H-Glu-Glu-OH
Claims (6)
1.一种用于从两个或更多个类型的水溶性生物物质的混合物中分离水溶性生物物质的方法,其使用由载体和通过化学键合与载体表面结合的多糖组成的分离剂通过层析进行。
2.根据权利要求1的方法,其中所述水溶性生物物质是选自糖、核酸化合物、氨基酸、水溶性维生素、具有生理活性的酸性化合物及其衍生物、和寡肽的一个或多个类型。
3.根据权利要求2的方法,其中所述多糖是纤维素或直链淀粉。
4.一种用于分离水溶性生物物质的分离剂,其由载体和通过化学键合与所述载体表面结合的多糖组成。
5.根据权利要求4的分离剂,其中所述水溶性生物物质是选自糖、核酸化合物、氨基酸、水溶性维生素、具有生理活性的酸性化合物及其衍生物、和寡肽的一个或多个类型。
6.根据权利要求5的分离剂,其中所述多糖是纤维素或直链淀粉。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010202070 | 2010-09-09 | ||
JP2010-202070 | 2010-09-09 | ||
PCT/JP2011/070599 WO2012033194A1 (ja) | 2010-09-09 | 2011-09-09 | 水溶性生体関連物質の分離方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103097887A true CN103097887A (zh) | 2013-05-08 |
Family
ID=45810790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800434683A Pending CN103097887A (zh) | 2010-09-09 | 2011-09-09 | 用于分离水溶性生物物质的方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20130165632A1 (zh) |
EP (1) | EP2615452A4 (zh) |
JP (1) | JP5926682B2 (zh) |
CN (1) | CN103097887A (zh) |
WO (1) | WO2012033194A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140061133A1 (en) * | 2012-08-31 | 2014-03-06 | Joseph Lewis HERMAN | Method and Apparatus for Split-Flow-Mixing Liquid Chromatography |
US10265643B2 (en) | 2014-07-17 | 2019-04-23 | Azyp, Llc | High efficiency, ultra-stable, bonded hydrophilic interaction chromatography (HILIC) matrix on superficially porous particles (SPPS) |
CN105424854B (zh) * | 2015-11-23 | 2016-07-13 | 济南英盛生物技术有限公司 | 一种同时检测血液样品中多种水溶性维生素的方法 |
CN113563396A (zh) * | 2020-04-29 | 2021-10-29 | 江苏汉邦科技有限公司 | 一种高纯维生素b12的制备方法 |
CN114002352B (zh) * | 2021-10-29 | 2023-01-24 | 四川汇宇制药股份有限公司 | 叶酸与其光学异构体的分离检测方法 |
CN115144508B (zh) * | 2022-09-02 | 2022-12-13 | 广州市乾相生物科技有限公司 | 一种适用于多种水溶性肽的hplc分离方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10132798A (ja) * | 1996-09-04 | 1998-05-22 | Daicel Chem Ind Ltd | 高速液体クロマトグラフィー用充填剤の製造法 |
WO1998048914A1 (en) * | 1997-04-25 | 1998-11-05 | Transgenomic, Inc. | Improved liquid chromatographic media for polynucleotide separation |
US20040124149A1 (en) * | 2002-09-13 | 2004-07-01 | Ciphergen Biosystems, Inc. | Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays |
JP2006102698A (ja) * | 2004-10-07 | 2006-04-20 | Sekisui Chem Co Ltd | イオン交換液体クロマトグラフィー用充填剤の製造方法 |
CN101259406A (zh) * | 2007-12-17 | 2008-09-10 | 南京工业大学 | 一种键合-亲合复合型多糖类手性固定相的制备方法 |
CN101766995A (zh) * | 2008-12-30 | 2010-07-07 | 中山海拓生物材料科技有限公司 | 键合型多糖类手性分离液相色谱固定相材料及其合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234991A (en) * | 1975-07-29 | 1993-08-10 | Pasteur Merieux Serums And Vaccines | Porous mineral support coated with an aminated polysaccharide polymer |
US4421568A (en) * | 1981-08-26 | 1983-12-20 | Hydrocarbon Research, Inc. | Process for making L-sugars and D-fructose |
JPS61181960A (ja) * | 1985-02-06 | 1986-08-14 | Daicel Chem Ind Ltd | 複合構造物 |
JP2504005B2 (ja) * | 1986-11-17 | 1996-06-05 | 東ソー株式会社 | 充填剤およびその製法 |
US5245024A (en) * | 1989-06-30 | 1993-09-14 | Loyola University Of Chicago | Cellulose chromatography support |
JP2751004B2 (ja) * | 1993-09-22 | 1998-05-18 | ダイセル化学工業株式会社 | 新規多糖誘導体,その製造法及びその用途 |
US6736967B2 (en) * | 2001-06-07 | 2004-05-18 | Daicel Chemical Industries, Ltd. | Separating agent for enantiomeric isomers |
DE60239060D1 (de) * | 2001-07-06 | 2011-03-10 | Daicel Chem | Neues trennmittel zur trennung eines optischen isomers und herstellungsverfahren dafür |
JP2004003935A (ja) * | 2002-04-12 | 2004-01-08 | Daicel Chem Ind Ltd | 擬似移動床式クロマトグラフィー用光学異性体分離用充填剤 |
JP4430881B2 (ja) * | 2003-03-18 | 2010-03-10 | ダイセル化学工業株式会社 | 液体クロマトグラフィー用光学異性体分離用充填剤の製造方法 |
US20090216006A1 (en) * | 2008-02-21 | 2009-08-27 | Hui Xu | Covalently bound polysaccharide-based chiral stationary phases and method for their preparation |
-
2011
- 2011-09-09 WO PCT/JP2011/070599 patent/WO2012033194A1/ja active Application Filing
- 2011-09-09 CN CN2011800434683A patent/CN103097887A/zh active Pending
- 2011-09-09 JP JP2012533041A patent/JP5926682B2/ja active Active
- 2011-09-09 EP EP11823668.6A patent/EP2615452A4/en not_active Ceased
- 2011-09-09 US US13/820,898 patent/US20130165632A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10132798A (ja) * | 1996-09-04 | 1998-05-22 | Daicel Chem Ind Ltd | 高速液体クロマトグラフィー用充填剤の製造法 |
WO1998048914A1 (en) * | 1997-04-25 | 1998-11-05 | Transgenomic, Inc. | Improved liquid chromatographic media for polynucleotide separation |
US20040124149A1 (en) * | 2002-09-13 | 2004-07-01 | Ciphergen Biosystems, Inc. | Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays |
JP2006102698A (ja) * | 2004-10-07 | 2006-04-20 | Sekisui Chem Co Ltd | イオン交換液体クロマトグラフィー用充填剤の製造方法 |
CN101259406A (zh) * | 2007-12-17 | 2008-09-10 | 南京工业大学 | 一种键合-亲合复合型多糖类手性固定相的制备方法 |
CN101766995A (zh) * | 2008-12-30 | 2010-07-07 | 中山海拓生物材料科技有限公司 | 键合型多糖类手性分离液相色谱固定相材料及其合成方法 |
Non-Patent Citations (4)
Title |
---|
ZHIMOU GUO ET AL.: "Synthesis, chromatographic evaluation and hydrophilic interaction/reversed-phase mixed-mode behavior of a "Click β-cyclodextrin" stationary phase", 《JOURNAL OF CHROMATOGRAPHY A》, vol. 1216, no. 2, 9 January 2009 (2009-01-09), pages 257 - 263, XP025817095, DOI: doi:10.1016/j.chroma.2008.11.071 * |
宋卿 等: "海藻糖、龙胆二糖、蜜二糖键合硅胶手性固定相的制备和性能", 《化学研究》, vol. 20, no. 2, 30 June 2009 (2009-06-30), pages 95 - 97 * |
蒋生祥 等: "硅胶基质高效液相色谱固定相", 《色谱》, vol. 25, no. 2, 31 March 2007 (2007-03-31), pages 163 - 173 * |
郭志谋 等: "亲水作用色谱固定相及其在中药分离中的应用", 《色谱》, vol. 27, no. 5, 30 September 2009 (2009-09-30), pages 675 - 681 * |
Also Published As
Publication number | Publication date |
---|---|
US20130165632A1 (en) | 2013-06-27 |
WO2012033194A1 (ja) | 2012-03-15 |
JPWO2012033194A1 (ja) | 2014-01-20 |
JP5926682B2 (ja) | 2016-05-25 |
EP2615452A1 (en) | 2013-07-17 |
EP2615452A4 (en) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ikegami et al. | Separation efficiencies in hydrophilic interaction chromatography | |
CN103097887A (zh) | 用于分离水溶性生物物质的方法 | |
Ikai et al. | Immobilized-type chiral packing materials for HPLC based on polysaccharide derivatives | |
Vergara-Barberan et al. | Solid-phase extraction based on ground methacrylate monolith modified with gold nanoparticles for isolation of proteins | |
US20060060516A1 (en) | Stimulus responsive affinity chromatographic material and separation/purification method | |
Fang et al. | Immobilized enzyme reactors in HPLC and its application in inhibitor screening: A review | |
Lü et al. | Preparation of chitosan functionalized monolithic silica column for hydrophilic interaction liquid chromatography | |
Cai et al. | A polyacrylamide-based silica stationary phase for the separation of carbohydrates using alcohols as the weak eluent in hydrophilic interaction liquid chromatography | |
Sheng et al. | A dextran-bonded stationary phase for saccharide separation | |
Perçin et al. | Mannose‐specific lectin isolation from Canavalia ensiformis seeds by PHEMA‐based cryogel | |
Lei et al. | Preparation of a biomimetic ionic liquids hybrid polyphosphorylcholine monolithic column for the high efficient capillary microextraction of glycopeptide antibiotics | |
KR100973749B1 (ko) | 의사이동상식 크로마토그래피를 이용하여 광학 이성체를 분리하는 방법 | |
Turková et al. | Hydroxyalkyl methacrylate gels derivatized with epichlorohydrin as supports for large-scale and high-performance affinity chromatography | |
JPWO2002030853A1 (ja) | 光学異性体分離用充填剤及びそれを用いた光学異性体の分離方法 | |
Liu et al. | Effects of spacer arm on penicillin G acylase purification using immobilized metal affinity membranes | |
US7223334B2 (en) | Separating agent for enantiomeric isomers | |
CN111239314B (zh) | 一种几丁寡糖的分离分析方法 | |
Jandera | Advances in hydrophilic interaction liquid chromatography | |
Zhao et al. | Microscale separation of heparosan, heparan sulfate, and heparin | |
Kwon et al. | High performance liquid chromatography of mono-and oligosaccharides derivatized with p-aminobenzoic ethyl ester on a C18-bonded silica column | |
Delattre et al. | Purification of oligouronides by immobilized L-histidine pseudoaffinity chromatography | |
JP3635002B2 (ja) | 液体クロマトグラフィー用光学異性体分離用充填剤 | |
JP2001163806A (ja) | 光学異性体分離剤 | |
CN101614710A (zh) | 高效液相色谱法分离测定地西他滨有关物质及其对应异构体的方法 | |
Ali et al. | Immobilization of styrene-acrylamide co-polymer on either silica particles or inner surface of silica capillary for the separation of d-Glucose anomers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130508 |